Get 15% Off on Memorial Day Sitewide Sale Get 15% Off on Memorial Day Sitewide Sale


FDA Approves Potentially Disastrous Cholesterol-Lowering Drug

Story at-a-glance -

  • A new class of dangerous cholesterol lowering agents called PCSK9 inhibitors increases your liver’s ability to remove low-density lipoprotein (LDL) from your blood by inactivating PCSK9, a high-level metabolic regulator in the liver
  • Results from a 78-week long study shows the PCSK9 inhibitor alirocumab (Praluent) causes higher incidence of many of the same side effects as statins
  • Some researchers warn this new class of drugs may promote liver problems, cancer, and health problems associated with cholesterol- and sulfate-deficiency

By Dr. Mercola

One in three Americans aged 40 and over take a cholesterol-lowering statin drug, and nearly half of people over age 75 are on them, despite their risks, and the fact that "high" cholesterol is not always the enemy it's made out to be.

Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and will soon be blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy